Skip to main content
Signal8

Schoenberg Mark

SEC insider (Form 3/4/5 filer). CIK 0001763581. Chief Medical Officer at UroGen Pharma Ltd. (URGN). 32 reported Form 4/5 transactions since Sep 2024; latest on Sep 8, 2026. Located in PRINCETON, NJ.

Companies Schoenberg Mark has filed insider reports for

  • UroGen Pharma Ltd. (URGN): Officer, Chief Medical Officer
Schoenberg Mark profile photo

Schoenberg Mark

CIK: 0001763581

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)18 (56.3%)

Position reduction

Option Exercises (M)12 (37.5%)

Derivative conversions

Awards (A)2 (6.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

UroGen Pharma Ltd. logo
URGN

UroGen Pharma Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (32 total)

  • UroGen Pharma Ltd. logo
    URGN

    UroGen Pharma Ltd.

    Sep 8, 2026
    Sale
    Direct
    871 shares at avg. $42.92$37K
  • UroGen Pharma Ltd. logo
    URGN

    UroGen Pharma Ltd.

    Sep 7, 2026
    Exercise
    Direct
    1.7K shares-
  • UroGen Pharma Ltd. logo
    URGN

    UroGen Pharma Ltd.

    Aug 20, 2026
    Sale
    Direct
    60.7K shares at avg. $47.05$2.9M
  • UroGen Pharma Ltd. logo
    URGN

    UroGen Pharma Ltd.

    Jul 9, 2026
    Sale
    Direct
    10K shares at avg. $40.00$400K
  • UroGen Pharma Ltd. logo
    URGN

    UroGen Pharma Ltd.

    Jun 22, 2026
    Sale
    Direct
    10K shares at avg. $35.01$350K
  • UroGen Pharma Ltd. logo
    URGN

    UroGen Pharma Ltd.

    Jun 8, 2026
    Exercise
    Direct
    10K shares-
  • UroGen Pharma Ltd. logo
    URGN

    UroGen Pharma Ltd.

    Jun 8, 2026
    Sale
    Direct
    5.2K shares at avg. $27.30$143K
  • UroGen Pharma Ltd. logo
    URGN

    UroGen Pharma Ltd.

    May 8, 2026
    Sale
    Direct
    10K shares at avg. $30.00$300K
  • UroGen Pharma Ltd. logo
    URGN

    UroGen Pharma Ltd.

    Feb 3, 2026
    Sale
    Direct
    1.8K shares at avg. $19.69$36K
  • UroGen Pharma Ltd. logo
    URGN

    UroGen Pharma Ltd.

    Feb 3, 2026
    Sale
    Direct
    1.8K shares at avg. $19.69$36K

1-10 of 32